Antibody Contract Development & Manufacturing Organization Market Size, Share & Trends Report

Antibody Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Product, By Source, By Therapeutic Area (Oncology, Neurology, Cardiology), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68040-116-7
  • Number of Report Pages: 175
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2021
  • Forecast Period: 2023 - 2030 
  • Industry: Healthcare

Market Segmentation

  • Antibody CDMO Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Others
  • Antibody CDMO Source Outlook (Revenue, USD Million, 2018 - 2030)
    • Mammalian
    • Microbial
  • Antibody CDMO Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    • Oncology
    • Neurology
    • Cardiology
    • Infectious Diseases
    • Immune-mediated Disorders
    • Others
  • Antibody CDMO End Use Outlook (Revenue, USD Million, 2018 - 2030)
    • Biopharmaceutical Companies
    • Research Laboratories
    • Others
  • Antibody CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Others
      • North America Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
        • Mammalian
        • Microbial
      • North America Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
        • Neurology
        • Cardiology
        • Infectious Diseases
        • Immune-mediated Disorders
        • Others
      • North America Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
        • Biopharmaceutical Companies
        • Research Laboratories
        • Others
      • U.S.
        • U.S. Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • U.S. Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • U.S. Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • U.S. Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Canada
        • Canada Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Canada Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Canada Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Canada Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
    • Europe
      • Europe Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Others
      • Europe Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
        • Mammalian
        • Microbial
      • Europe Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
        • Neurology
        • Cardiology
        • Infectious Diseases
        • Immune-mediated Disorders
        • Others
      • Europe Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
        • Biopharmaceutical Companies
        • Research Laboratories
        • Others
      • UK​​​​​​​​​​​​​​
        • UK Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • UK Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • UK Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • UK Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Germany
        • Germany Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Germany Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Germany Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Germany Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • France
        • France Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • France Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • France Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • France Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Italy
        • Italy Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Italy Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Italy Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Italy Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Spain
        • Spain Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Spain Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Spain Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Spain Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Denmark
        • Denmark Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Denmark Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Denmark Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Denmark Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Sweden
        • Sweden Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Sweden Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Sweden Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Sweden Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Norway
        • Norway Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Norway Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Norway Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Norway Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
    • Asia Pacific​​​​​​​
      • Asia Pacific Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Others
      • Asia Pacific Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
        • Mammalian
        • Microbial
      • Asia Pacific Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
        • Neurology
        • Cardiology
        • Infectious Diseases
        • Immune-mediated Disorders
        • Others
      • Asia Pacific Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
        • Biopharmaceutical Companies
        • Research Laboratories
        • Others
      • Japan
        • Japan Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Japan Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Japan Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Japan Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • China
        • China Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • China Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • China Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • China Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • India
        • India Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • India Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • India Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • India Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Australia
        • Australia Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Australia Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Australia Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Australia Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Thailand
        • Thailand Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Thailand Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Thailand Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Thailand Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • South Korea
        • South Korea Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • South Korea Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • South Korea Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • South Korea Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
    • Latin America
      • Latin America Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Others
      • Latin America Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
        • Mammalian
        • Microbial
      • Latin America Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
        • Neurology
        • Cardiology
        • Infectious Diseases
        • Immune-mediated Disorders
        • Others
      • Latin America Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
        • Biopharmaceutical Companies
        • Research Laboratories
        • Others
      • Brazil
        • Brazil Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Brazil Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Brazil Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Brazil Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Mexico
        • Mexico Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Mexico Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Mexico Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Mexico Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Argentina
        • Argentina Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Argentina Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Argentina Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Argentina Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
    • Middle East & Africa
      • Middle East & Africa Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Others
      • Middle East & Africa Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
        • Mammalian
        • Microbial
      • Middle East & Africa Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
        • Neurology
        • Cardiology
        • Infectious Diseases
        • Immune-mediated Disorders
        • Others
      • Middle East & Africa Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
        • Biopharmaceutical Companies
        • Research Laboratories
        • Others
      • South Africa ​​​​​​​
        • South Africa Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • South Africa Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • South Africa Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • South Africa Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Saudi Arabia
        • Saudi Arabia Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Saudi Arabia Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Saudi Arabia Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Saudi Arabia Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • UAE ​​​​​​​
        • UAE Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • UAE Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • UAE Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • UAE Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others
      • Kuwait
        • Kuwait Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Monoclonal Antibodies
          • Polyclonal Antibodies
          • Others
        • Kuwait Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
          • Mammalian
          • Microbial
        • Kuwait Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
          • Neurology
          • Cardiology
          • Infectious Diseases
          • Immune-mediated Disorders
          • Others
        • Kuwait Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
          • Biopharmaceutical Companies
          • Research Laboratories
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon